Insights

Innovative Oncology Focus IGI is actively developing advanced biologics in oncology, targeting complex hematological and solid tumor cancers with first-in-class Multispecifics™ platforms, presenting opportunities for partners in targeted biologic development.

Strategic Partnerships Recent collaborations with the National Cancer Institute and development of specialized treatments like ISB 2001 indicate potential for joint research initiatives, licensing, and co-development opportunities in innovative cancer therapeutics.

Pipeline Expansion IGI's focus on addressing unmet medical needs through novel treatments for relapsed/refractory multiple myeloma and triple negative breast cancer provides avenues to align with pharmaceutical companies seeking innovative oncology assets.

Funding and Revenue Potential With revenues between $10M and $50M and ongoing product development, IGI may be open to strategic investments, licensing deals, or partnership models to accelerate clinical progression and commercialization of their pipeline.

Technological Edge Powered by proprietary BEAT® technology, IGI's focus on biologics and personalized treatment platforms positions it as a valuable partner for companies seeking frontier biotech innovations with high therapeutic potential.

Similar companies to Ichnos Glenmark Innovation

Ichnos Glenmark Innovation Tech Stack

Ichnos Glenmark Innovation uses 8 technology products and services including RSS, oEmbed, Microsoft 365, and more. Explore Ichnos Glenmark Innovation's tech stack below.

RSS
Content Management System
oEmbed
Dev Tools
Microsoft 365
Email
Google Fonts API
Font Scripts
Slick
Javascript Libraries
jQuery
Javascript Libraries
Elementor
Page Builders
Cloudflare Bot Management
Security

Media & News

Ichnos Glenmark Innovation's Email Address Formats

Ichnos Glenmark Innovation uses at least 2 format(s):

Ichnos Glenmark Innovation Email Formats	Example	Percentage
First.Last@ichnossciences.com	John.Doe@ichnossciences.com	82%
First_Last@ichnossciences.com	John_Doe@ichnossciences.com	5%
FirstL@ichnossciences.com	JohnD@ichnossciences.com	2%
FirLast@ichnossciences.com	JohDoe@ichnossciences.com	2%
Last_First@ichnossciences.com	Doe_John@ichnossciences.com	1%
Last.First@ichnossciences.com	Doe.John@ichnossciences.com	2%
Last@ichnossciences.com	Doe@ichnossciences.com	1%
First-Last@ichnossciences.com	John-Doe@ichnossciences.com	1%
LastFir@ichnossciences.com	DoeJoh@ichnossciences.com	1%
LastFirst@ichnossciences.com	DoeJohn@ichnossciences.com	1%
FirstLast@ichnossciences.com	JohnDoe@ichnossciences.com	1%
First.Middle@ichnossciences.com	John.Michael@ichnossciences.com	1%

Frequently Asked Questions

Where is Ichnos Glenmark Innovation's headquarters located?

Ichnos Glenmark Innovation's main headquarters is located at 1 World Trade Center, 76th Floor, Suite D New York, NY 10007, US. The company has employees across 4 continents, including EuropeNorth AmericaAsia.

What is Ichnos Glenmark Innovation's stock symbol?

Ichnos Glenmark Innovation is a publicly traded company; the company's stock symbol is IGI.

What is Ichnos Glenmark Innovation's official website and social media links?

Ichnos Glenmark Innovation's official website is iginnovate.com and has social profiles on LinkedIn.

What is Ichnos Glenmark Innovation's SIC code NAICS code?

Ichnos Glenmark Innovation's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ichnos Glenmark Innovation have currently?

As of October 2025, Ichnos Glenmark Innovation has approximately 185 employees across 4 continents, including EuropeNorth AmericaAsia. Key team members include Chief Scientific Officer: M. P.Chief Medical Officer: L. P.Chief Process And Manufacturing Officer: R. G.. Explore Ichnos Glenmark Innovation's employee directory with LeadIQ.

What industry does Ichnos Glenmark Innovation belong to?

Ichnos Glenmark Innovation operates in the Biotechnology Research industry.

What technology does Ichnos Glenmark Innovation use?

Ichnos Glenmark Innovation's tech stack includes RSSoEmbedMicrosoft 365Google Fonts APISlickjQueryElementorCloudflare Bot Management.

What is Ichnos Glenmark Innovation's email format?

Ichnos Glenmark Innovation's email format typically follows the pattern of First.Last@ichnossciences.com. Find more Ichnos Glenmark Innovation email formats with LeadIQ.

When was Ichnos Glenmark Innovation founded?

Ichnos Glenmark Innovation was founded in 2019.

Ichnos Glenmark Innovation

Q: How many employees does Ichnos Glenmark Innovation have currently?

Ichnos Glenmark Innovation has approximately 185 employees.

Q: What technology does Ichnos Glenmark Innovation use?

Ichnos Glenmark Innovation's tech stack includes RSS, Yoast SEO, Priority Hints, jQuery Migrate, JSON-LD.

Biotechnology ResearchUnited States51-200 Employees

IGI, Inc. is a global, fully integrated clinical-stage biotechnology company focused on developing innovative biologics in oncology. 

Headquartered in New York, NY, IGI is advancing a robust pipeline of novel, first-in-class Multispecifics™ aimed at addressing complex diseases and treating patients holistically. Powered by its proprietary BEAT® technology platform, IGI is committed to delivering breakthrough, curative therapies to improve and extend the lives of patients battling hematological malignancies and solid tumors.

Company Overview

Headquarters: 1 World Trade Center, 76th Floor, Suite D New York, NY 10007, US
Website: iginnovate.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: IGI
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2019
Employees: 51-200